Although many Americans are at risk of developing colorectal cancer, they may not be aware of their own specific risk factors that they could have for it. What should medical professionals be teaching their patients about on regarding the risks, symptoms, detection, and prevention of colorectal cancer?
The “watch and wait” approach is characterized by close surveillance without surgery in patients with rectal cancer who achieve a clinical CR following neoadjuvant CRT.
Get the latest treatment options for rectal cancer, including concurrent chemotherapy and radiotherapy and levoleucovorin plus 5-FU.
Neoadjuvant RT recommended for stage II to III rectal cancer; RT should be performed preoperatively.
Suspected local disease regrowth was seen in 23% of patients with rectal cancer observed following a near or complete clinical response to neoadjuvant therapy.
Early results from the Polish II study showed a significant improvement in OS for preoperative short-course RT/chemotherapy compared with long-term chemo-RT.
Researchers sought to measure adherence to topical management regimens among patients with HFSR due to treatment with regorafenib.
A retrospective review of data from the National Cancer Data Base demonstrated that trends in rectal cancer may follow a pattern similar to that of colon cancer.
Incidence of colon and rectal cancers are increasing sharply in people younger than 50 years, the recommended age for initiating screening.
Outcomes improved with short-course radiation and delay to surgery of 4 to 8 weeks.
